Study of RAD001 in Adenoid Cystic Carcinoma

NCT01152840 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Adenoid Cystic Carcinoma

Interventions

DRUG: RAD001

Sponsor

Seoul National University Hospital